Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Surgeons who routinely perform cataract surgery could better help patients by learning basic glaucoma procedures and incorporating them into cataract surgery, according to two glaucoma surgeons who spoke to EyeWorld. They discussed how cataract surgeons can gain experience with glaucoma procedures and when it makes sense to incorporate them.
➤ Meeting with FDA to advance therapy for Leber congenital amaurosis ➤ 36-month data from first-in-human bimatoprost-IOL system ➤ 20-week data from study evaluating treatment for patients with macular edema secondary to inflammation ➤ Interim data from Phase 1/2 trial for wet AMD therapy ➤ Company news ➤ ASCRS news and events
➤ Topline Phase 3 results for low-dose atropine drop ➤ 12-month data from prospective pilot study assessing aqueous shunt ➤ 5-year follow-up data supports safety, tolerability of investigational retinitis pigmentosa treatment. ➤ Randomization achieved in registrational trial for wet AMD therapy ➤ BLA submitted for thyroid eye disease treatment ➤ Company news ➤ ASCRS news and events
➤ FDA approves epithelium-on crosslinking treatment ➤ 12-month results from Phase 1/2 trial evaluating regenerative cell therapy for corneal endothelial disease ➤ Phase 3 data supports nonsteroidal treatment for uveitic macular edema ➤ FDA approves IDE for glaucoma device ➤ Company news ➤ ASCRS news and events
➤ New trifocal receives FDA approval ➤ Robotic system completes its first cataract surgery ➤ Interim results from first-in-human bimatoprost-IOL system ➤ Reproducible regenerative effects observed in preclinical glaucoma model ➤ Phase 3 program begins for intravitreal insert treating wet AMD, DME ➤ ASCRS news and events
The ocular surface impacts many ophthalmic subspecialties beyond cornea. Whether it’s within refractive surgery, cataract surgery, glaucoma therapy, or retina procedures, the ocular surface can affect outcomes for patients being treated by these subspecialists. Several anterior segment ophthalmologists spoke about the ocular surface and how it relates to their subspecialty.
“The challenges we face in glaucoma care, whether it's understanding complex conditions like pigmentary glaucoma or adopting transformative technologies like DSLT, are the very impetus for our continuous innovation and growth,” concluded Glaucoma Editor Manjool Shah, MD, after sharing his thoughts on these article topics.
Three glaucoma experts spoke to EyeWorld about pigment dispersion syndrome and pigmentary glaucoma, from diagnosis to treatment and monitoring, and what they want anterior segment surgeons who are not necessarily glaucoma specialists to know about it.
➤ Priority review granted to possible LHON treatment ➤ Update on drug in development for neuropathic corneal pain ➤ FDA approves generic bimatoprost ➤ Phase 1/2a clinical results for first-in-human retinal pigment epithelial stem cell therapy ➤ Adult dosing complete in trial for X-linked retinoschisis therapy ➤ Company news ➤ ASCRS news and events
The DSLT laser (Voyager, Alcon) became commercially available in the U.S. earlier this year, and many surgeons are beginning to incorporate this into their glaucoma treatment paradigm. Several physicians discussed this new technology, how it compares to SLT, and how they’re using it in their practices.
Get the latest ophthalmology news delivered to your inbox every Friday.